| RS2540124973 |
PEX5
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2540125931 |
PEX5
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2540127265 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540129675 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540129721 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Achondrogenesis type II, Achondrogenesis type II |
| RS2540131856 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540131993 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540132104 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540132208 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540132223 |
COL2A1
|
Health Risk |
Pathogenic |
Achondrogenesis type II, Achondrogenesis type II |
| RS2540132967 |
SDHAF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS2540133028 |
SDHAF2
|
Health Risk |
Likely pathogenic |
Pheochromocytoma/paraganglioma syndrome 2, Pheochromocytoma/paraganglioma syndrome 2 |
| RS2540133883 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540133960 |
COL2A1
|
Health Risk |
Likely pathogenic |
Achondrogenesis type II, Achondrogenesis type II |
| RS2540134070 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540134084 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540134211 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540134243 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540134393 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540134446 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540135652 |
COL2A1
|
Health Risk |
Likely pathogenic |
COL2A1-related disorder, COL2A1-related disorder |
| RS2540135688 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS2540135722 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540135979 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540136030 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540136183 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540136191 |
COL2A1
|
Health Risk |
Likely pathogenic |
Spondyloepiphyseal dysplasia congenita, Spondyloepiphyseal dysplasia congenita |
| RS2540136240 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2540138276 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540138496 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540139870 |
COL2A1
|
Health Risk |
Likely pathogenic |
COL2A1-related disorder, COL2A1-related disorder |
| RS2540139953 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS2540141581 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540141594 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome, Stickler syndrome |
| RS2540141840 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2540143151 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540143179 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540143186 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540143217 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540143322 |
COL2A1
|
Health Risk |
Likely pathogenic |
COL2A1-related disorder, COL2A1-related disorder |
| RS2540144358 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS2540144667 |
COL2A1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2540144774 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540144824 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540144871 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540146311 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540146769 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540146864 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540147368 |
COL2A1
|
Health Risk |
Likely pathogenic |
Spondyloepiphyseal dysplasia congenita, Type 2 collagenopathy |
| RS2540147394 |
LHX2
|
Health Risk |
Likely pathogenic |
Variable neurodevelopmental disorder, Variable neurodevelopmental disorder |
| RS2540147569 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS2540148055 |
PEX5
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2540148386 |
PEX5
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2540148810 |
COL2A1
|
Health Risk |
Likely pathogenic |
Stickler syndrome, type I |
| RS2540148817 |
COL2A1
|
Health Risk |
Likely pathogenic |
COL2A1-related disorder, COL2A1-related disorder |
| RS2540148926 |
PEX5
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2540149005 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540149264 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540149322 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540149361 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540149390 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome, type I |
| RS2540150838 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540150852 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS2540150856 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540150901 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540150938 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540151593 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540151614 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540151727 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
COL2A1-related disorder, COL2A1-related disorder |
| RS2540151735 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540151785 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540151788 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Achondrogenesis type II, Achondrogenesis type II |
| RS2540152086 |
COL2A1
|
Health Risk |
Pathogenic |
Kniest dysplasia, Kniest dysplasia |
| RS2540152190 |
COL2A1
|
Health Risk |
Likely pathogenic |
Spondyloepimetaphyseal dysplasia, Strudwick type |
| RS2540153237 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540153326 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540153331 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540153474 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540153512 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540154732 |
SCN8A
|
Health Risk |
Likely pathogenic |
— |
| RS2540154868 |
SCN8A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS2540155977 |
SCN8A
|
Health Risk |
Likely pathogenic |
Cognitive impairment with or without cerebellar ataxia, Cognitive impairment with or without cerebellar ataxia |
| RS2540157034 |
ACVRL1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2540157150 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS2540157346 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540157602 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540158011 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2540158104 |
ACVRL1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2540158127 |
ACVRL1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2540158136 |
ACVRL1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2540158145 |
ACVRL1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Telangiectasia |
| RS2540158250 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS2540158265 |
ACVRL1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Telangiectasia |
| RS2540158303 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2540158384 |
ACVRL1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2540158393 |
ACVRL1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2540158399 |
ACVRL1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2540158414 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS2540158554 |
ACVRL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Telangiectasia |
| RS2540158607 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Telangiectasia |